Eligible patients may pay as little as
Glaucoma is a disease that damages the eye’s optic nerve, often caused by extra fluid that increases pressure in the eye.
Open-angle glaucoma is the most common form of glaucoma. It develops gradually and often goes unnoticed at first. Regular eye exams are important to find early signs of damage to the optic nerve.
While there is no cure for glaucoma, studies show that lowering high eye pressure can help reduce the risk of glaucoma-related vision loss. That's why daily treatment of high eye pressure is very important. Remember, high eye pressure can slowly, but permanently, damage your optic nerve before you notice any change in vision.
Your doctor can recommend a prescription eye drop to help manage your glaucoma or high eye pressure. One option is LUMIGAN® 0.01%.
LUMIGAN® 0.01% is an FDA-approved prescription medication used to treat open-angle glaucoma or ocular hypertension. There is no FDA-approved generic version of LUMIGAN® 0.01%. If your doctor prescribes LUMIGAN® 0.01%, check to make sure you receive the correct medication when you pick it up.
Prescription eye drops are commonly used to reduce high eye pressure. LUMIGAN® 0.01% is an FDA-approved medication proven to lower high eye pressure in newly diagnosed or already-treated patients with open-angle glaucoma or ocular hypertension.
The recommended dose for LUMIGAN® 0.01% is 1 drop in the affected eye(s) once a day in the evening. If you use more than 1 topical eye drop, just be sure to apply them at least 5 minutes apart.
If you have open-angle glaucoma or ocular hypertension, it is important to continue your LUMIGAN® 0.01% therapy. Don’t skip or stop treatment (unless you have spoken to your doctor). Remembering to use your eye drops is easier if you make it part of your daily routine.
If you wear contact lenses, remove them first, then wait 15 minutes after using LUMIGAN® 0.01% before you put them back into your eyes.
In a year-long study of 560 patients, the most common side effects seen in the 185 patients treated with LUMIGAN® 0.01% were eye redness (31.4%), eyelash growth (3.8%), and itchy eyes (3.8%). If you start to feel continued eye itching, consult your doctor. In a clinical study, 1.6% (n=3) of patients stopped therapy due to eye redness with LUMIGAN® 0.01%. If you develop a new eye condition, you should seek your doctor’s advice concerning the continued use of LUMIGAN® 0.01%.
Eligible customers can qualify to pay as little as $15 for 90 days of medication.* To access savings on your LUMIGAN® 0.01% prescription, enroll online here. You can also enroll for discounts by calling 1-833-Dial-AYS (1-833-342-5297), or texting SAVINGS to 72428.
*Offer not valid for patients enrolled in Medicare, Medicaid, a Medicare drug benefit plan, TRICARE, or other federal or state health programs (such as medical assistance programs). Other limitations may apply. This offer is valid for up to 12 prescription fills for a 30-day supply and 4 prescription fills for a 90-day supply per medication. Offer applies only to prescriptions filled before the program expires on 05/01/20. This offer cannot be combined with any other programs, offers, or discounts, and may not be redeemed for cash. Allergan reserves the right to rescind, revoke, or amend this offer without notice at any time.
The information provided in this website is intended for U.S. healthcare professionals only. I certify that I am a U.S. healthcare professional.